Cigna Corporation (CI) Insider Sells $4,262,718.57 in Stock

Cigna Corporation (NYSE:CI) insider Matthew G. Manders sold 24,357 shares of the company’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $175.01, for a total value of $4,262,718.57. Following the completion of the sale, the insider now directly owns 46,256 shares of the company’s stock, valued at $8,095,262.56. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Cigna Corporation (NYSE CI) opened at 174.38 on Friday. The company has a market cap of $43.91 billion, a PE ratio of 20.12 and a beta of 0.46. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $178.57. The firm’s 50-day moving average price is $172.22 and its 200 day moving average price is $159.17.

Cigna Corporation (NYSE:CI) last issued its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 7.46%. The business’s revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.98 earnings per share. On average, equities analysts predict that Cigna Corporation will post $10.02 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Cigna Corporation (CI) Insider Sells $4,262,718.57 in Stock” was first published by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://transcriptdaily.com/2017/08/13/matthew-g-manders-sells-24357-shares-of-cigna-corporation-ci-stock-updated-updated.html.

Several hedge funds have recently modified their holdings of CI. Guardian Life Insurance Co. of America raised its stake in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after buying an additional 7 shares during the last quarter. Private Trust Co. NA purchased a new stake in shares of Cigna Corporation during the first quarter valued at about $205,000. Asset Advisors Corp raised its stake in Cigna Corporation by 7.3% in the first quarter. Asset Advisors Corp now owns 29,845 shares of the health services provider’s stock worth $4,372,000 after buying an additional 2,025 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Cigna Corporation during the fourth quarter worth about $1,109,000. Finally, Wetherby Asset Management Inc. raised its stake in Cigna Corporation by 3.5% in the first quarter. Wetherby Asset Management Inc. now owns 4,159 shares of the health services provider’s stock worth $609,000 after buying an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 86.91% of the company’s stock.

CI has been the subject of a number of recent analyst reports. Zacks Investment Research raised Cigna Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, April 18th. Jefferies Group LLC reiterated a “buy” rating and issued a $178.00 price objective (up from $172.00) on shares of Cigna Corporation in a research report on Sunday, April 23rd. Stifel Nicolaus boosted their price objective on Cigna Corporation from $170.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, May 5th. Royal Bank Of Canada boosted their price objective on Cigna Corporation from $172.00 to $177.00 and gave the company an “outperform” rating in a research report on Monday, May 8th. Finally, Deutsche Bank AG boosted their price objective on Cigna Corporation from $172.00 to $175.00 and gave the company a “buy” rating in a research report on Wednesday, May 10th. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $180.06.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply